Mein Warenkorb

Cadherin-6

Cadherin-6 Molekülinformation

Englischer NameCadherin-6Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5Target-AliasKidney cadherin,K-cadherin,Cadherin 6, Type 2, K-Cadherin (Fetal Kidney),K-Cadherin,Cadherin-6,Kidney Cadherin,CAD6,KCAD
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameCadherin-6
Target-AliasKidney cadherin,K-cadherin,Cadherin 6, Type 2, K-Cadherin (Fetal Kidney),K-Cadherin,Cadherin-6,Kidney Cadherin,CAD6,KCAD
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel5
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

Cadherin-6 Produktliste

  • Attribut

    Protein (9)Cell (1)Beads (1)

  • Produktbibliothek

    Online (11)

  • Spezies

    Human (7)Cynomolgus / Rhesus macaque (2)Mouse (1)Rat (1)

  • Etikett

    His Tag (4)Fc Tag (4)His Tag & Avi Tag (1)- (2)

  • Marker

    Unconjugated (8)Biotin-labeled (1)- (2)

Cadherin-6 Molekülhintergrund

Cadherin-6 (CDH6) is also known as Kidney cadherin (K-cadherin or KCAD), is a a type II classical cadherin from the cadherin superfamily. Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. CDH6 / KCAD contains five cadherin domains. CDH6 is highly expressed in brain, cerebellum, and kidney. Lung, pancreas, and gastric mucosa show a weak expression and also expressed in certain liver and kidney carcinomas.

Cadherin-6 Molekülalias

CDH6,CAD6,KCAD,K-cadherin,Cadherin-6

Antikörperprojekt-Handelsplattform

ProjektnameProjektphaseMolekültypMolekülquelleKrankheitsgebietIndikationen
CDH6 mAb - 01PCCMonoclonalHumanized MouseSolid TumorOvarian cancer,Renal cell carcinoma

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Raludotatug deruxtecanDS-6000a; DS6000a; DS-6000; R-DXd; MK-5909Phase 3 ClinicalDaiichi Sankyo Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours
Details
QLS-5133QLS-5133; QLS5133Phase 2 ClinicalQilu Pharmaceutical Co LtdSolid tumours
Details
HS-20124HS-20124; HS20124Phase 1 ClinicalHansoh BioMedical R&D CompanySolid tumours
Details
SIM-0505SIM-0505Phase 1 ClinicalHainan Xiansheng Re Ming Pharmaceutical Co LtdSolid tumours
Details
AMT-707AMT-707; CUSP-06Phase 1 ClinicalMultitude Therapeutics IncCarcinoma, Renal Cell; Cholangiocarcinoma; Ovarian Neoplasms; Solid tumours
Details

Produktrezensionen

  • Molekülinformation
  • Produktliste
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns